z-logo
open-access-imgOpen Access
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Author(s) -
Alana F. Ogata,
ChiAn Cheng,
Michaël Desjardins,
Yasmeen Senussi,
Amy C Sherman,
Megan Powell,
Lewis A. Novack,
Salena S Von,
Xiaofang Li,
Lindsey R. Baden,
David R. Walt
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab465
Subject(s) - medicine , coronavirus , covid-19 , antibody , immunology , respiratory system , virology , immunoglobulin g , severe acute respiratory syndrome coronavirus , severe acute respiratory syndrome , antigen , infectious disease (medical specialty) , disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. Eleven of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day 1 after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of immunoglobulin G (IgG) and immunoglobulin A (IgA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom